Stevanato Group S.p.A. (NYSE:STVN) Stock Holdings Lifted by Pier Capital LLC

Pier Capital LLC grew its stake in shares of Stevanato Group S.p.A. (NYSE:STVN) by 2.9% in the fourth quarter, Holdings Channel.com reports. The fund owned 381,624 shares of the company’s stock after buying an additional 10,627 shares during the quarter. Pier Capital LLC’s holdings in Stevanato Group were worth $8,316,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of STVN. TimesSquare Capital Management LLC increased its position in shares of Stevanato Group by 114.6% in the fourth quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock worth $71,657,000 after acquiring an additional 1,756,100 shares in the last quarter. Jennison Associates LLC acquired a new position in Stevanato Group in the 4th quarter worth approximately $20,239,000. Mutual of America Capital Management LLC purchased a new position in Stevanato Group during the 4th quarter worth approximately $13,848,000. Teacher Retirement System of Texas raised its stake in Stevanato Group by 56.3% during the 4th quarter. Teacher Retirement System of Texas now owns 1,250,000 shares of the company’s stock valued at $27,238,000 after purchasing an additional 450,000 shares during the period. Finally, New York State Common Retirement Fund purchased a new stake in shares of Stevanato Group in the fourth quarter valued at $8,879,000.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on STVN shares. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Bank of America lifted their target price on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Wolfe Research began coverage on shares of Stevanato Group in a research report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. UBS Group lowered their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research report on Friday, March 7th. Finally, William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of €27.75 ($29.84).

Stevanato Group Trading Down 0.8 %

NYSE:STVN opened at €22.34 ($24.02) on Tuesday. The company has a market capitalization of $6.77 billion, a P/E ratio of 47.53, a P/E/G ratio of 7.18 and a beta of 0.60. The stock’s 50 day moving average price is €21.04 and its 200 day moving average price is €20.59. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. Stevanato Group S.p.A. has a 52 week low of €16.56 ($17.81) and a 52 week high of €33.49 ($36.01).

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, hitting the consensus estimate of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. On average, research analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.